Skip to main content
. 2020 Mar 19;3:134. doi: 10.1038/s42003-020-0863-y

Fig. 5. Diagnostic performance of the discrimination model at different stages and histological types of lung cancer.

Fig. 5

a Diagnostic performance of the two selected miRNAs at different pathological TNM stages in the validation set. The diagnostic index showed high performance for all stages. Each positive rate is shown in the plot. b Diagnostic performance of the two selected miRNAs at different histological types in the validation set. The diagnostic index showed high performance for all histological types. Each positive rate is shown in the plot.